LT-A36

General Information


DRACP ID  DRACP06088

Peptide Name   LT-A36

Sequence  FHAVEALA

Sequence Length  8

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic (Derived from SLIT2 protein)

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C40H60N10O11

Absent amino acids  CDGIKMNPQRSTWY

Common amino acids  A

Mass  98203

Pl  5.36

Basic residues  1

Acidic residues  1

Hydrophobic residues  6

Net charge  0

Boman Index  590

Hydrophobicity  118.75

Aliphatic Index  122.5

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN111032679A

Patent Title  Peptides for Cancer Treatment

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.